Risk Factors
424 articles
Identify Your Risk Early
Long-term survivor Scott Nelson was diagnosed with pancreatic cancer, so older brother Steve joined a screening study, which caught his cancer at its earliest stages.
A Second Opinion: Important for Pancreatic Cancer Patients
Dr. Allyson Ocean and Dr. Jordan Winter explain why getting a second opinion can be of great benefit for pancreatic cancer patients.
Unraveling the Web for Reliable Pancreatic Cancer Information
Dr. Mark Lewis and journalist Steve Doig explain how to judge whether the information about pancreatic cancer on the internet is from a reliable source.
Drafting Your Health Care Team
If you have pancreatic cancer, a treatment team of experts from across the medical profession will make sure you get the best care.
My BRCA2 Mutation Turned Out to Be Both the Curse and the Cure
Sharon Seibel knew she had the BRCA2 mutation but was unaware of the link to pancreatic cancer. Her chemotherapy was one for BRCA carriers.
Genomic Testing of Pancreatic Tumor Leads to an Important Discovery
Connie Waxman learned the value of palliative care after chemotherapy, radiation, and a pancreatectomy for pancreatic cancer; then she had genomic testing.
Maintenance Chemotherapy Trial for Pancreatic Cancer Patients with the BRCA Mutation
A clinical trial for patients with BRCA mutations uses a PARP inhibitor as part of the maintenance chemotherapy experimental treatment.
Younger Brother’s Pancreatic Cancer Leads to Regular Screening for his Oldest Brother
When Scott Nelson was diagnosed with pancreatic cancer, oldest brother Steve began regular screening, which lead to his early diagnosis.
Tumor RNA Testing Leads to Treatment with a New Drug
When treatment stopped working for Adam Deal, genetic testing of his tumor RNA found a mutation that made him eligible to try a new drug.
BRCA Mutation Determines My Pancreatic Cancer Treatment
Chris Treubert started with one type of chemotherapy but when the results of genetic testing showed a BRCA mutation he changed treatment.
Fighting Pancreatic Cancer in a Petri Dish
Dr. David Tuveson is growing pancreatic cancer tissue called organoids in the lab, to test which drugs will be most effective against a patient’s tumor.
Immunotherapy Treatments Provide Hope to Pancreatic Cancer Patients
Dr. Robert Vonderheide of the Abramson Cancer Center at the University of Pennsylvania describes immunotherapy trials for pancreatic cancer.
The Cancer Moonshot
Dr. Elizabeth Jaffee of Johns Hopkins is part of the Cancer Moonshot’s Blue Ribbon Panel, and she explains the goals of the program.
Developing a Screening Test for Pancreatic Cancer
One focus of research for Dr. Anirban Maitra is to develop a simple screening test for pancreatic cancer, to provide an earlier diagnosis of the disease.
Synergy with Metronomic Chemotherapy
Oncologists are trying metronomic chemotherapy, lower doses of toxic drugs given on a steady basis, to fight pancreatic cancer.